The anchoring trials are STEP (semaglutide for weight management, NEJM 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Dichlorvos is moderately to highly toxic for mammals (the oral LD 50 for the rat is 30 - 110 mg/kg body weight)
BPC-157 works through several interconnected healing pathways
While charging, the red LED is lit
The Wells Fargo ESOP Fund seeks long-term capital growth through investment primarily in Wells Fargo & Company common stock. The Wells Fargo & Company common stock in the Wells Fargo ESOP Fund is held in a unitized fund, which means that the fund, in addition to the common stock, holds a small percentage of the assets in short-term cash equivalent investments to meet the daily liquidity needs of the Wells Fargo ESOP Fund for plan investment transfers and distributions, and the investors hold units of the Wells Fargo ESOP Fund instead of shares of Wells Fargo & Company common stock directly
